uz
Feedback

Firibgarlarga uchmang! Telemetrio bunday kanallarni topadi va belgilaydi 👉 Belgini ko‘rmoqchi bo‘lsangiz, obuna bo‘ling

Introduction Modules | سنة أولى طب

Introduction Modules | سنة أولى طب

Kanalga Telegram’da o‘tish

Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Ko'proq ko'rsatish

📈 Telegram kanali Introduction Modules | سنة أولى طب analitikasi

Introduction Modules | سنة أولى طب (@introduction_modules) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 31 009 obunachidan iborat bo'lib, Tibbiyot toifasida 650-o'rinni va Misr mintaqasida 576-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 31 009 obunachiga ega bo‘ldi.

03 Noyabr, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 1 767 ga, so‘nggi 24 soatda esa 13 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 16.34% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 3.07% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 5 059 marta ko‘riladi; birinchi sutkada odatda 952 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 5 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent module, general, microbiology, summary, بارا kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
“Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2”

Yuqori yangilanish chastotasi (oxirgi ma’lumot 04 Noyabr, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

31 009
Obunachilar
+1324 soatlar
+2757 kun
+1 76730 kun
Postlar arxiv
شرح medicine is easy فسيو 👇👇 #Physiology

25 - Revision of Tut 3,chemotherapy, Pharmacology.mp4 Quality : 🎬 480p

24 - Revision of Tut 2, Drug interaction, pharmacology..mp4 Quality : 🎬 480p

23 - Revision of Tut 1,Dose response curve, pharmacology.mp4 Quality : 🎬 480p

22 - Revision of L12, Cholinergic pharmacology 2 (Parasympathomimetics), Pharmacology.mp4 Quality : 🎬 480p

21 - Revision of L11, cholinergic pharmacology 1 ( parasympatholytics), pharmacology.mp4 Quality : 🎬 480p

20 - Revision of L9,10, Adrenergic Pharmacology (sympatholytic), Pharmacology.mp4 Quality : 🎬 480p

19 - CBL1(clinical application of B2 agonist) and Revision of L7,8(Adrenergic Pharmacology), Pharmacology.mp4 Quality : 🎬 480p

18 - Revision of L5,6, pharmacodynamics, pharmacology.mp4 Quality : 🎬 480p

17 - Revision of L4, pharmacokinetics (excretion), pharmacology.mp4 Quality : 🎬 480p

16 - Revision of L3, pharmacokinetics (metabolism), pharmacology.mp4 Quality : 🎬 480p

15 - Revision of L2 ,Pharmacokinetics 2 (distribution) , Pharmacology.mp4 Quality : 🎬 480p

14 - Revision of L1 Pharmacokinetics(Absorption ), Pharmacology.mp4 Quality : 🎬 480p

شرح نجاح بدون جشع فارما 👇👇 #Physiology

25 - Revision of Tut 3,chemotherapy, Pharmacology.mp4 Quality : 🎬 480p

24 - Revision of Tut 2, Drug interaction, pharmacology..mp4 Quality : 🎬 480p

23 - Revision of Tut 1,Dose response curve, pharmacology.mp4 Quality : 🎬 480p

22 - Revision of L12, Cholinergic pharmacology 2 (Parasympathomimetics), Pharmacology.mp4 Quality : 🎬 480p

21 - Revision of L11, cholinergic pharmacology 1 ( parasympatholytics), pharmacology.mp4 Quality : 🎬 480p

20 - Revision of L9,10, Adrenergic Pharmacology (sympatholytic), Pharmacology.mp4 Quality : 🎬 480p